Search results for: 'formulation component ship'

This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differentiation increasingly shaped by clinical evidence, ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent technology advances across cell & gene therapies, immunotherapies, intelligent drug discovery approaches, automated biomanufacturing and microbiome sciences. The TOE also encompasses recent developments in proteomics, drug deliver...

The study presents an in-depth exploration of novel functional ingredients designed to enhance mental and emotional well-being, identifying the overall drivers of growth, technological change, and market opportunities through 2030. Mental health disorders continue to present a serious global challenge, with anxiety and depression affecting more tha...

Remote patient monitoring (RPM) is gaining momentum as a variety of factors create a significant need for the value propositions that RPM promises. The report states that the overall RPM market is expected to increase at a compound annual growth rate of 19.8% from 2017 to 2023. RPM refers to the use of telecommunications technology to enable pat...

The global healthcare IT and digital health investment landscape is entering a new maturity curve, shaped by AI-driven operational transformation, consolidation, and platform-centric models. Funding is rebounding selectively, with capital concentrating in enterprise infrastructure, provider operations, and hybrid virtual care ecosystems. Administra...

This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...

09 Feb 2021  |  North America  |  Market Research

COVID-19 Pandemic Ignites Enthusiasm for Virtual Care

Competitors’ Growth Strategies will Shape the Way the Market Opportunity Crystallizes

Infographics

×

There is no one definition for virtual care, but Frost & Sullivan defines it in this research as a technical platform that maintains an interactive connectivity between patients, providers, and payers where various processes and services may be scheduled, accessed, monitored, and entered into the medical record without the need for manual calls or ...

21 May 2021  |  North America  |  Market Research

Explosion of Data Drives the US Social Determinants of Health Market

Proven Returns on Investment will Ignite Transformational Growth

Infographics

×

This report from Frost & Sullivan Healthcare and Life Sciences focuses on the potential to cater to healthcare needs based on data-driven social determinants of health (SDOH). Although the traditional practice of healthcare involves the use of medical technology and protocols to maintain and restore health, the SDOH concept adds another dimension. ...